Solar based hydrogen generation: EU-project PECSYS aiming for technological breakthrough

Scientists from all participating organisations together with the project officers from FCH2 JU met in January 2017 to start off the project.

Scientists from all participating organisations together with the project officers from FCH2 JU met in January 2017 to start off the project. © J. Bierbaum/HZB

Development of demonstrators measuring up to ten square meters in area planned

The HZB is coordinating a Horizon 2020 EU project that is expected to develop an economically feasible technology for solar based hydrogen generation. Solar energy shall thereby be converted into chemical energy that can be stored as fuel by hydrogen. The project’s approach shall ensure that the levelised cost of hydrogen production remains below five Euros per kilogramme. The partners hailing from Germany, Sweden and Italy plan to ultimately build an array of modules covering ten square meters to demonstrate stable device performance on a large area. The project runs for four years and is funded with 2.5 million euros.

Currently, photovoltaics (PV) covers about 7.4 percent of the net electricity demand in Germany and on sunny weekends, this even rises to 50 percent. However, PV cannot generate electricity at night and in conditions with high cloud cover. Nevertheless, PV cells can be combined with electro-catalysts in order to split water into its constituent elements, hydrogen and water. This solar generated hydrogen thus stores solar energy in a chemical form and releases it, as required for example at night, via a fuel cell.  Although in recent years research in this area has made much progress, up till now, unlike PV, no technological scale up to large areas has been accomplished. In other words: the race is currently wide open.

Partners in Germany, Italy, Sweden

This challenge will now be addressed by the PECSYS project: the project is coordinated by the Competence Centre Thin Film and Nanotechnology for Photovoltaics Berlin (PVcomB) at the HZB and brings together expertise from the Forschungszentrum Juelich, Germany; Uppsala University, Sweden; the National Research Council of Italy and from two corporations namely, Solibro Research AB, Sweden and 3SUN, Italy.

6 percent efficiency for 6 months

Dr Sonya Calnan, the spokesperson of the project and a researcher at HZB acknowledges, “The aims of the project are ambitious and very definite”: The demonstrator system to be developed is expected to be realised on an area of at least ten square meters, to convert more than six percent of the incident solar energy into hydrogen and to maintain stable operation for at least six months. Also, the cost of the so-generated hydrogen should be less than five euro per kilogramme. For comparison: the actual market price for hydrogen is about eight euro per kilogramme.

Integrated device

At PVcomB, photovoltaic cells based on different materials such as silicon and chalcogenides, as well as tandem cells based on metal halide perovskites, together with electro-catalysts and membranes shall be tested and protective layers developed. The goal is to ultimately develop an integrated device that can stably operate under extreme environmental conditions.

Appropriate for industrial production

The participating project teams thus aim to identify a system that is most appropriate for industrial production. The demonstrator systems with a total area of ten square metres shall then be installed at either Forschungzentrum Jülich and/or at 3SUN and produce at least ten kg of hydrogen in six months.

The project has received funding from the Fuel Cells and Hydrogen 2 Joint Undertaking under grant agreement No 735218. This Joint Undertaking receives support from the European Union’s Horizon 2020 Research and Innovation programme and Hydrogen Europe and N.ERGHY.

> PECSYS Homepage

arö

  • Copy link

You might also be interested in

  • Green hydrogen: MXenes shows talent as catalyst for oxygen evolution
    Science Highlight
    09.09.2024
    Green hydrogen: MXenes shows talent as catalyst for oxygen evolution
    The MXene class of materials has many talents. An international team led by HZB chemist Michelle Browne has now demonstrated that MXenes, properly functionalised, are excellent catalysts for the oxygen evolution reaction in electrolytic water splitting. They are more stable and efficient than the best metal oxide catalysts currently available. The team is now extensively characterising these MXene catalysts for water splitting at the Berlin X-ray source BESSY II and Soleil Synchrotron in France.
  • SpinMagIC: 'EPR on a chip' ensures quality of olive oil and beer
    News
    04.09.2024
    SpinMagIC: 'EPR on a chip' ensures quality of olive oil and beer
    The first sign of spoilage in many food products is the formation of free radicals, which reduces the shelf-life and the overall quality of the food. Until now, the detection of these molecules has been very costly for the food companies. Researchers at HZB and the University of Stuttgart have developed a portable, small and inexpensive 'EPR on a chip' sensor that can detect free radicals even at very low concentrations. They are now working to set up a spin-off company, supported by the EXIST research transfer programme of the German Federal Ministry of Economics and Climate Protection. The EPRoC sensor will initially be used in the production of olive oil and beer to ensure the quality of these products.
  • Review on ocular particle therapy (OPT) by international experts
    Science Highlight
    03.09.2024
    Review on ocular particle therapy (OPT) by international experts
    A team of leading experts in medical physics, physics and radiotherapy, including HZB physicist Prof. Andrea Denker and Charité medical physicist Dr Jens Heufelder, has published a review article on ocular particle therapy. The article appeared in the Red Journal, one of the most prestigious journals in the field. It outlines the special features of this form of eye therapy, explains the state of the art and current research priorities, provides recommendations for the delivery of radiotherapy and gives an outlook on future developments.